TW202305127A - 用於改良磷酸轉移酶之材料及方法 - Google Patents
用於改良磷酸轉移酶之材料及方法 Download PDFInfo
- Publication number
- TW202305127A TW202305127A TW111114949A TW111114949A TW202305127A TW 202305127 A TW202305127 A TW 202305127A TW 111114949 A TW111114949 A TW 111114949A TW 111114949 A TW111114949 A TW 111114949A TW 202305127 A TW202305127 A TW 202305127A
- Authority
- TW
- Taiwan
- Prior art keywords
- amino acid
- seq
- npt
- cells
- nucleic acid
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
- C12Y207/01095—Kanamycin kinase (2.7.1.95), i.e. neomycin-kanamycin phosphotransferase
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (16)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163177767P | 2021-04-21 | 2021-04-21 | |
| US202163177749P | 2021-04-21 | 2021-04-21 | |
| US202163177759P | 2021-04-21 | 2021-04-21 | |
| US202163177744P | 2021-04-21 | 2021-04-21 | |
| US202163177746P | 2021-04-21 | 2021-04-21 | |
| US202163177753P | 2021-04-21 | 2021-04-21 | |
| US202163177764P | 2021-04-21 | 2021-04-21 | |
| US202163177739P | 2021-04-21 | 2021-04-21 | |
| US63/177,753 | 2021-04-21 | ||
| US63/177,749 | 2021-04-21 | ||
| US63/177,759 | 2021-04-21 | ||
| US63/177,767 | 2021-04-21 | ||
| US63/177,746 | 2021-04-21 | ||
| US63/177,764 | 2021-04-21 | ||
| US63/177,739 | 2021-04-21 | ||
| US63/177,744 | 2021-04-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202305127A true TW202305127A (zh) | 2023-02-01 |
Family
ID=83722653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW111114949A TW202305127A (zh) | 2021-04-21 | 2022-04-20 | 用於改良磷酸轉移酶之材料及方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240191215A1 (https=) |
| EP (1) | EP4326747A4 (https=) |
| JP (1) | JP2024516153A (https=) |
| KR (1) | KR20230173159A (https=) |
| AU (1) | AU2022261882A1 (https=) |
| BR (1) | BR112023021960A2 (https=) |
| CA (1) | CA3217224A1 (https=) |
| IL (1) | IL307870A (https=) |
| MX (1) | MX2023012514A (https=) |
| TW (1) | TW202305127A (https=) |
| WO (1) | WO2022226005A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7344886B2 (en) * | 2002-11-29 | 2008-03-18 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene product |
| KR101149777B1 (ko) * | 2002-11-29 | 2012-06-11 | 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 | 신규한 네오마이신 포스포트랜스퍼라제 유전자 및 고생산성 재조합 세포의 선별 방법 |
| US20080124760A1 (en) * | 2006-07-26 | 2008-05-29 | Barbara Enenkel | Regulatory Nucleic Acid Elements |
| EP1975228A1 (en) * | 2007-03-28 | 2008-10-01 | Fachhochschule Mannheim | Polynucleotides for enhancing expression of a polynucleotide of interest |
| AU2011342162B2 (en) * | 2010-12-15 | 2017-04-20 | Kyowa Kirin Co., Ltd. | Method for producing proteins |
| US11389531B2 (en) * | 2017-12-19 | 2022-07-19 | Janssen Sciences Ireland Unlimited Company | Methods and apparatus for the delivery of hepatitis B virus (HBV) vaccines |
-
2022
- 2022-04-20 CA CA3217224A patent/CA3217224A1/en active Pending
- 2022-04-20 US US18/287,742 patent/US20240191215A1/en active Pending
- 2022-04-20 MX MX2023012514A patent/MX2023012514A/es unknown
- 2022-04-20 IL IL307870A patent/IL307870A/en unknown
- 2022-04-20 AU AU2022261882A patent/AU2022261882A1/en not_active Abandoned
- 2022-04-20 WO PCT/US2022/025452 patent/WO2022226005A1/en not_active Ceased
- 2022-04-20 BR BR112023021960A patent/BR112023021960A2/pt not_active Application Discontinuation
- 2022-04-20 JP JP2023564448A patent/JP2024516153A/ja active Pending
- 2022-04-20 EP EP22792366.1A patent/EP4326747A4/en active Pending
- 2022-04-20 KR KR1020237039725A patent/KR20230173159A/ko active Pending
- 2022-04-20 TW TW111114949A patent/TW202305127A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3217224A1 (en) | 2022-10-27 |
| US20240191215A1 (en) | 2024-06-13 |
| IL307870A (en) | 2023-12-01 |
| JP2024516153A (ja) | 2024-04-12 |
| WO2022226005A1 (en) | 2022-10-27 |
| MX2023012514A (es) | 2024-01-05 |
| EP4326747A1 (en) | 2024-02-28 |
| EP4326747A4 (en) | 2025-06-11 |
| AU2022261882A1 (en) | 2023-12-07 |
| BR112023021960A2 (pt) | 2023-12-26 |
| KR20230173159A (ko) | 2023-12-26 |
| AU2022261882A9 (en) | 2023-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107502618B (zh) | 可控载体消除方法及易用型CRISPR-Cas9工具 | |
| CN107988246A (zh) | 一种基因敲除载体及其斑马鱼胶质瘤模型 | |
| CN113906134B (zh) | Tau蛋白病模型 | |
| KR20180056772A (ko) | 세포내 유전자 변형 및 증가된 상동 재조합을 위한 보호 dna 주형 및 이용 방법 | |
| CN111836825A (zh) | 优化的植物crispr/cpf1系统 | |
| CN112680477B (zh) | 一种基于无缝克隆技术的h9n2亚型禽流感病毒的拯救方法 | |
| CN110343698B (zh) | 构建B2m定点敲入人B2M cDNA小鼠模型的方法 | |
| KR101755965B1 (ko) | Il33 n―말단 도메인 결실을 갖는 염증의 쥣과 모델 | |
| CN117561273A (zh) | 用于经改善的磷酸转移酶的材料和方法 | |
| TW202305127A (zh) | 用於改良磷酸轉移酶之材料及方法 | |
| CA2743775A1 (en) | .beta.gi-igg intron for enhanced anti-igf1r expression | |
| CN102361977B (zh) | 衍生自丙型肝炎病毒的核酸以及通过使用该核酸各自制备的表达载体、转化细胞和丙型肝炎病毒颗粒 | |
| US6730481B2 (en) | Primers-attached vector elongation (PAVE): a 5′-directed cDNA cloning strategy | |
| AU2023218196A1 (en) | Method for predicting off-target which can occur in process of editing genome by using prime editing system | |
| US9085767B2 (en) | Enhancer-containing gene trap vectors for random and targeted gene trapping | |
| CN117305334B (zh) | 靶向整合细胞及其制备方法、生产目标基因表达产物的方法 | |
| CN111378626B (zh) | 一种cho细胞系、构建方法、重组蛋白表达系统、应用 | |
| CN112342216B (zh) | 用于提高CHO细胞的表达效率的CRISPR-Cas13d系统以及重组CHO细胞 | |
| CA2394792C (en) | Promoter and intron from maize actin depolymerizing factor | |
| US6699657B2 (en) | In vitro system for replication of RNA-dependent RNA polymerase (RDRP) viruses | |
| CN100363498C (zh) | 家蚕丝腺生物反应器及其构建方法 | |
| CN115029347B (zh) | 识别和调控肝肾细胞纤维化的分子监测序列、重组质粒、抑制病毒 | |
| CN112342240B (zh) | 用于表达rFC蛋白的59R突变载体及其制备方法和应用 | |
| CN111100876A (zh) | CRISPR-Cas9特异性敲除FAH基因的方法及特异性sgRNA | |
| KR20250167611A (ko) | 유전자 발현 구축물용 스페이서 |